Kentanix Supra International Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Kentanix Supra International Tbk. trades at Rp280 (market cap 594.32B, 17K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Kentanix Supra International Tbk. is far larger — about 3.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 17K). Which is the better fit depends on your goals.
| KSIX | OBAT | |
|---|---|---|
Market Cap | 594.32B | 167.37B |
Volume | 17K | 96.7K |
Lot | 170 | 967 |
Turnover | 4.73M | 23.82M |
Average Price | 278.14 | 246.34 |
Value | 4.73M | 23.82M |
Indicative Equilibrium Price | 278 | 248 |
Indicative Equilibrium Volume | 500 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kentanix Supra International Tbk (the Company) was established based on Notarial Deed No. 41 dated October 27, 1980 of Samsul Hadi, S.H., as amended by Deed No. 25 dated April 8, 1981 and Deed No. 10 dated October 9, 1981 of the same Notary. The Company commenced its commercial operations in 1985. PT Badra Arta, a company incorporated in Indonesia, is the parent entity of the Company.
Read more on KSIX →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →